EXAMINE THIS REPORT ON MBL77

Whilst very low-rely MBL not often progresses to CLL, substantial-count MBL progresses to CLL necessitating therapy at a fee of 1% to 2% per annum. High-count MBL is distinguished from Rai 0 CLL according to if the B-mobile count is earlier mentioned or beneath five × 109/L. Although persons with both of those higher-count MBL and CLL Rai phase 0